Skip to main content
. 2015 Oct 14;30(3):181–185. doi: 10.11138/FNeur/2015.30.3.181

Table II.

Baseline (pre-treatment) frequency of seizures in patients receiving zinc supplementation versus placebo.

Frequency Zinc
n (%)
Placebo
n (%)
p-value
> 5/day 3 (13%) 3 (14%) 0.31*
1–5/day 2 (9%) 3 (14%)
1–5/week 10 (43%) 8 (36%)
1–5/month 8 (35%) 8 (36%)
Total 23 (100%) 22 (100%)
*

Mantel-Haenszel summary chi-square, stratified by center.